Search

everythinglearnresearchcommunity

for

Search:↓

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Overweight women with PCOS are more likely to have excess male hormones.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Testosterone is important for male development and health, and careful replacement can treat low levels.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.